Cargando…

The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?

Amyotrophic lateral sclerosis (ALS) is a degenerating disease involving the motor neurons, which causes a progressive loss of movement ability, usually leading to death within 2 to 5 years from the diagnosis. Much effort has been put into research for an effective therapy for its eradication, but st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bassani, Davide, Pavan, Matteo, Federico, Stephanie, Spalluto, Giampiero, Sturlese, Mattia, Moro, Stefano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106011/ https://www.ncbi.nlm.nih.gov/pubmed/35562894 http://dx.doi.org/10.3390/ijms23094504

Ejemplares similares

A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δ
por: Bolcato, Giovanni, et al.
Publicado: (2021)

Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
por: Pavan, Matteo, et al.
Publicado: (2022)

Sodium or Not Sodium: Should Its Presence Affect the Accuracy of Pose Prediction in Docking GPCR Antagonists?
por: Bassani, Davide, et al.
Publicado: (2022)

From the Wuhan-Hu-1 strain to the XD and XE variants: is targeting the SARS-CoV-2 spike protein still a pharmaceutically relevant option against COVID-19?
por: Pavan, Matteo, et al.
Publicado: (2022)

Investigating RNA–protein recognition mechanisms through supervised molecular dynamics (SuMD) simulations
por: Pavan, Matteo, et al.
Publicado: (2022)

Supervised Molecular Dynamics (SuMD) Insights into the mechanism of action of SARS-CoV-2 main protease inhibitor PF-07321332
por: Pavan, Matteo, et al.
Publicado: (2021)

Re-Exploring the Ability of Common Docking Programs to Correctly Reproduce the Binding Modes of Non-Covalent Inhibitors of SARS-CoV-2 Protease M(pro)
por: Bassani, Davide, et al.
Publicado: (2022)

Ribose and Non-Ribose A2A Adenosine Receptor Agonists: Do They Share the Same Receptor Recognition Mechanism?
por: Bolcato, Giovanni, et al.
Publicado: (2022)

Implementing a Scoring Function Based on Interaction Fingerprint for Autogrow4: Protein Kinase CK1δ as a Case Study
por: Pavan, Matteo, et al.
Publicado: (2022)

Qualitative Estimation of Protein–Ligand Complex Stability through Thermal Titration Molecular Dynamics Simulations
por: Pavan, Matteo, et al.
Publicado: (2022)

Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia
por: Ranganathan, Ramya, et al.
Publicado: (2020)

Inspecting the Mechanism of Fragment Hits Binding on SARS‐CoV‐2 M(pro) by Using Supervised Molecular Dynamics (SuMD) Simulations
por: Bissaro, Maicol, et al.
Publicado: (2021)

Editorial: Multifaceted Genes in Amyotrophic Lateral Sclerosis-Frontotemporal Dementia
por: Conforti, Francesca Luisa, et al.
Publicado: (2021)

The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications
por: Guo, Wenting, et al.
Publicado: (2020)

The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives
por: Federico, Stephanie, et al.
Publicado: (2015)

Riluzole–Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis
por: Albertini, Claudia, et al.
Publicado: (2022)

Oligodendrocyte Dysfunction in Amyotrophic Lateral Sclerosis: Mechanisms and Therapeutic Perspectives
por: Raffaele, Stefano, et al.
Publicado: (2021)

Current view and perspectives in amyotrophic lateral sclerosis
por: Mathis, Stéphane, et al.
Publicado: (2017)

Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives
por: Falzone, Yuri Matteo, et al.
Publicado: (2021)

Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir
por: Bolcato, Giovanni, et al.
Publicado: (2020)

Thermal Titration Molecular Dynamics (TTMD): Not Your Usual Post-Docking Refinement
por: Menin, Silvia, et al.
Publicado: (2023)

Insights on the Multifaceted Roles of Wild-Type and Mutated Superoxide Dismutase 1 in Amyotrophic Lateral Sclerosis Pathogenesis
por: Rubino, Valentina, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Familial amyotrophic lateral sclerosis, a historical perspective
por: Siddique, T., et al.
Publicado: (2011)

RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective
por: Laneve, Pietro, et al.
Publicado: (2021)

Microglial crosstalk with astrocytes and immune cells in amyotrophic lateral sclerosis
por: Calafatti, Matteo, et al.
Publicado: (2023)

Thermal titration molecular dynamics (TTMD): shedding light on the stability of RNA-small molecule complexes
por: Dodaro, Andrea, et al.
Publicado: (2023)

Extracellular Vesicles in Amyotrophic Lateral Sclerosis
por: McCluskey, Gavin, et al.
Publicado: (2022)

Purinergic implication in amyotrophic lateral sclerosis—from pathological mechanisms to therapeutic perspectives
por: Cieślak, M., et al.
Publicado: (2018)

Amyotrophic lateral sclerosis disease modifying therapeutics: a cell biological perspective
por: Tang, Bor Luen
Publicado: (2017)

Amyotrophic Lateral Sclerosis and Novel Therapeutic Strategies
por: Morrison, Brett, et al.
Publicado: (2012)

Novel therapeutic targets for amyotrophic lateral sclerosis
por: Batra, Gitika, et al.
Publicado: (2019)

Current and emerging treatments for amyotrophic lateral sclerosis
por: Zoccolella, Stefano, et al.
Publicado: (2009)

Sensory neuropathy in amyotrophic lateral sclerosis: a systematic review
por: Bombaci, Alessandro, et al.
Publicado: (2023)

Maximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives
por: Khairoalsindi, Osama A., et al.
Publicado: (2018)

Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives
por: Boentert, Matthias
Publicado: (2019)

Patient perspectives on transitioning to amyotrophic lateral sclerosis multidisciplinary clinics
por: Schellenberg, Kerri Lynn, et al.
Publicado: (2018)

Cortical Thinning and Clinical Heterogeneity in Amyotrophic Lateral Sclerosis
por: Mezzapesa, Domenico Maria, et al.
Publicado: (2013)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n9289l7igvl81od31hvd141bke